Shu‐Yung Lin

428 total citations
24 papers, 300 citations indexed

About

Shu‐Yung Lin is a scholar working on Infectious Diseases, Surgery and Molecular Biology. According to data from OpenAlex, Shu‐Yung Lin has authored 24 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Shu‐Yung Lin's work include Tuberculosis Research and Epidemiology (6 papers), Diagnosis and treatment of tuberculosis (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Shu‐Yung Lin is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Diagnosis and treatment of tuberculosis (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Shu‐Yung Lin collaborates with scholars based in Taiwan and United States. Shu‐Yung Lin's co-authors include Chong‐Jen Yu, Hsing-Chen Tsai, Chao‐Chi Ho, Hsuan‐Hsuan Lu, Chia‐Lin Hsu, Won‐Young Lee, Chih‐Hsien Wang, Sheng‐Hong Tseng, Jin‐Yuan Shih and Feng‐Ming Tien and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Shu‐Yung Lin

21 papers receiving 295 citations

Peers

Shu‐Yung Lin
Gianluca Businello Italy
Stephanie L. Ong United States
Zhiwen Lu China
Lu Pan China
Yoshimasa Otani Japan
Marco A. Durán-Padilla Mexico
Lishu Zhao China
Upasana Kulkarni Germany
Gaetano Di Terlizzi Italy
Heng Lu China
Gianluca Businello Italy
Shu‐Yung Lin
Citations per year, relative to Shu‐Yung Lin Shu‐Yung Lin (= 1×) peers Gianluca Businello

Countries citing papers authored by Shu‐Yung Lin

Since Specialization
Citations

This map shows the geographic impact of Shu‐Yung Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Yung Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Yung Lin more than expected).

Fields of papers citing papers by Shu‐Yung Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Yung Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Yung Lin. The network helps show where Shu‐Yung Lin may publish in the future.

Co-authorship network of co-authors of Shu‐Yung Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Yung Lin. A scholar is included among the top collaborators of Shu‐Yung Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Yung Lin. Shu‐Yung Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lin, Shu‐Yung, et al.. (2024). The prevalence, clinical reasoning and impact of non-standard anti-tuberculosis regimens at the initial prescription. Scientific Reports. 14(1). 5631–5631. 1 indexed citations
3.
Huang, Chun‐Ta, Ching‐Yao Yang, Shu‐Yung Lin, et al.. (2024). Spray nozzle for topical anaesthesia during flexible bronchoscopy: a randomised controlled trial. ERJ Open Research. 10(2). 913–2023. 1 indexed citations
4.
Chen, Tom Wei‐Wu, et al.. (2024). A case of primary pleural epithelioid hemangioendothelioma achieving stable disease with paclitaxel treatment: A case report and literature review. SHILAP Revista de lepidopterología. 12(4). e01341–e01341.
5.
Lin, Shu‐Yung, Hung‐Hsiang Liou, Chien‐Chia Chen, et al.. (2023). Protective Effect of BCG and Neutrophil-to-Lymphocyte Ratio on Latent Tuberculosis in End Stage Renal Disease. Infectious Diseases and Therapy. 12(7). 1907–1920. 4 indexed citations
6.
Tien, Feng‐Ming, Hsuan‐Hsuan Lu, Shu‐Yung Lin, & Hsing-Chen Tsai. (2023). Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities. Journal of Biomedical Science. 30(1). 3–3. 25 indexed citations
7.
Weng, Rueyhung Roc, Hsuan‐Hsuan Lu, Chien‐Ting Lin, et al.. (2021). Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer. Nature Communications. 12(1). 2163–2163. 22 indexed citations
8.
Lin, Shu‐Yung, Jia‐Yih Feng, Chih‐Yuan Lee, et al.. (2020). Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study. Antimicrobial Agents and Chemotherapy. 65(3). 1 indexed citations
9.
Lu, Hsuan‐Hsuan, Shu‐Yung Lin, Rueyhung Roc Weng, et al.. (2020). Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma. EBioMedicine. 57. 102846–102846. 28 indexed citations
10.
Lin, Ching‐Kai, Li‐Ta Keng, Yen‐Ting Lin, et al.. (2019). Diagnosis of mediastinal tuberculous lymphadenitis using endobronchial ultrasound-guided transbronchial needle aspiration with rinse fluid polymerase chain reaction. Journal of the Formosan Medical Association. 119(1). 509–515. 11 indexed citations
11.
Lu, Hsuan‐Hsuan, Shu‐Yung Lin, Rueyhung Roc Weng, et al.. (2019). Fucosyltransferase 4 Shapes Oncogenic Glycoproteome to Drive Metastasis of Lung Adenocarcinoma. SSRN Electronic Journal. 1 indexed citations
12.
Lin, Fang‐Ju, et al.. (2018). Concomitant use of Repaglinide and Clopidogrel And Risk Of Hypoglycemia: A Population-Based Nested Case-Control Study. Value in Health. 21. S36–S36. 1 indexed citations
13.
Lin, Shu‐Yung, Ching‐Yao Yang, Bin-Chi Liao, et al.. (2018). Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan. Journal of Cancer. 9(10). 1813–1820. 44 indexed citations
14.
Keng, Li‐Ta, Kuei‐Pin Chung, Shu‐Yung Lin, et al.. (2017). Significant Clinical Factors Associated with Long-term Mortality in Critical Cancer Patients Requiring Prolonged Mechanical Ventilation. Scientific Reports. 7(1). 2148–2148. 8 indexed citations
15.
Liao, Bin-Chi, Jih‐Hsiang Lee, Chia‐Chi Lin, et al.. (2017). Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors. Journal of the Formosan Medical Association. 117(4). 326–331. 11 indexed citations
16.
Ho, Chao‐Chi, Ching‐Kai Lin, Ching‐Yao Yang, et al.. (2016). Current advances of endobronchial ultrasonography in the diagnosis and staging of lung cancer. Journal of Thoracic Disease. 8(S9). S690–S696. 4 indexed citations
17.
Chung, Kuei‐Pin, Hou-Tai Chang, Shyh‐Chyi Lo, et al.. (2015). Severe Lymphopenia Is Associated with Elevated Plasma Interleukin-15 Levels and Increased Mortality During Severe Sepsis. Shock. 43(6). 569–575. 67 indexed citations
18.
Wang, Chih‐Hsien, et al.. (2003). Multiple deep-seated cavernomas in the third ventricle, hypothalamus and thalamus. Acta Neurochirurgica. 145(6). 505–508. 26 indexed citations
19.
Chen, Shyh‐Jye, et al.. (1997). Cavernoma of the central nervous system: Surgical experience in the magnetic resonance imaging era. 6(2). 171–178. 1 indexed citations
20.
Lin, Shu‐Yung, et al.. (1994). Intraoperative transcranial electrical motor evoked potential monitoring during spinal surgery under intravenous ketamine or etomidate anaesthesia. Acta Neurochirurgica. 127(3-4). 191–198. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gianluca Businello Breakdown of academic impact, for papers by Stephanie L. Ong Breakdown of academic impact, for papers by Zhiwen Lu Breakdown of academic impact, for papers by Lu Pan Breakdown of academic impact, for papers by Yoshimasa Otani Breakdown of academic impact, for papers by Marco A. Durán-Padilla Breakdown of academic impact, for papers by Lishu Zhao Breakdown of academic impact, for papers by Upasana Kulkarni Breakdown of academic impact, for papers by Gaetano Di Terlizzi Breakdown of academic impact, for papers by Heng Lu
Rankless by CCL
2026